Clinitech Laboratory Ltd

Clinitech Laboratory Annual General Meeting

Clinitech Laboratory Limited held its 16th Annual General Meeting on September 24, 2026. Shareholders transacted items including financial statement adoption and director re-appointment.

Clinitech Laboratory Annual General Meeting

Clinitech Laboratory Limited has released its Annual Report for FY 2025-26 and notice for the Annual General Meeting to be held on September 24, 2026.

Clinitech Laboratory Board Meeting Outcome

Clinitech Laboratory Limited's board approved the FY 2025-26 report and convened its 16th Annual General Meeting. The meeting also finalized book closure dates and appointed a voting scrutinizer.

Clinitech Laboratory Board Meeting Date

Clinitech Laboratory Ltd scheduled a Board Meeting for August 17, 2026. The board will discuss director appointments and the 16th AGM.

Clinitech Laboratory Fund Raise of ₹5.78 Cr

Clinitech Laboratory Ltd reported zero deviation in the utilization of INR 578.30 Lakhs raised through its IPO. Funds were deployed primarily for diagnostic center expansion.

Value

₹5.78 Cr

Clinitech Laboratory H2 FY26 Results: Net Profit ₹0.1 Cr, Down 50.0% YoY

Clinitech Laboratory Ltd reported revenue from operations of ₹4.4 Cr (+4.8% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for H2 FY26.

Key figure

Net profit ₹0.1 Cr · -50.0% YoY

Clinitech Laboratory Board Meeting Outcome

Clinitech Laboratory Limited approved audited standalone and consolidated financial results for FY 2025-26. The board also reviewed internal audits and approved related party transactions for FY 2026-27.

Clinitech Laboratory Board Meeting Date

Clinitech Laboratory scheduled a board meeting for May 28, 2026, to approve audited financial results. The trading window remains closed until 48 hours after announcement.

Clinitech Laboratory Partnership

Clinitech Laboratory Limited signed an MOU with M/s. MD Plus Multispeciality Clinic on April 25, 2026. The agreement involves operating a pathology lab and managing pickup points for pathology and referral radiology. This collaboration aims to expand the company's service reach through a strategic clinic partnership.

Clinitech Laboratory Other Announcement

Clinitech Laboratory Limited submitted an undertaking regarding the non-applicability of Related Party Transaction disclosures for the period ended March 31, 2026. The company is exempt under SEBI LODR Regulation 15 as it is listed on the BSE SME portal and does not exceed the specified threshold limits.

Clinitech Laboratory Other Announcement

Clinitech Laboratory Limited submitted an undertaking regarding the non-applicability of the Annual Secretarial Compliance Report for the year ended March 31, 2026. As an SME-listed entity on the BSE, the company is exempt from this requirement under Regulation 15(2) of SEBI (LODR) Regulations, 2015.

Clinitech Laboratory Partnership

Clinitech Laboratory Limited has appointed Kalpalabdhi Financials Private Limited as its new Market Maker effective April 10, 2026. This follows the discontinuation of SVCM Securities Private Limited due to internal restructuring. A tripartite agreement has been executed with Inventure Merchant Banker Services to formalize this arrangement.

Execution

Effective from April 10, 2026

Clinitech Laboratory Other Announcement

Clinitech Laboratory Limited submitted a compliance certificate for the quarter ended March 31, 2026. The Registrar and Transfer Agent, Bigshare Services, confirmed that all shares remain in dematerialized form and no rematerialisation requests were received during the period.

Clinitech Laboratory Promoter Buying

Clinitech Laboratory Ltd's promoter, Jagdish Umakant Nayak, acquired 9,600 additional equity shares on March 30, 2026. The company also confirmed that promoters and persons acting in concert have not created any encumbrances on their shareholdings during the financial year ended March 31, 2026.